Weight loss peptides (GLP-1 agonists) Examples : Semaglutide, Tirzepatide, Liraglutide Common side effects (mostly GI-related): Nausea : Frequency: 40-50% of users initially Severity: Mild to moderate Duration: Usually 1-3 weeks (improves with continued use) Management: Start low dose, increase gradually, eat smaller meals Constipation : Frequency: 20-30% of users Severity: Mild to moderate Management: Increase fiber, water, consider stool softener Diarrhea : Frequency: 15-20% of users Severity: Mild Duration: Usually temporary Management: Probiotics, reduce fatty foods Fatigue : Frequency: 20-30% initially Severity: Mild to moderate Duration: 2-4 weeks (improves as caloric deficit stabilizes) Management: Adequate protein, electrolytes, patience Reduced appetite (intended effect): Not a side effect - this is the mechanism Goal: 15-20% reduction in caloric intake Result: Weight loss Read our semaglutide vs tirzepatide comparison
Obesity and prevalent and incident CKD: the hypertension detection and follow-up program
Genetic variants in the ADH1B and ALDH2 genes affect the speed of alcohol metabolism
Lifestyle Modifications : Adopting healthy lifestyle habits such as regular exercise, adequate sleep, stress management, and avoiding toxins can help preserve glutathione levels and promote overall well-being
Reviewed by the PeptideMind Team Updated July 16, 2026 CJC-1295/Ipamorelin Blend (CJC-1295 (without DAC), Ipamorelin) Dosage Guide, Benefits & Side Effects This GHRH plus ghrelin-agonist blend amplifies pulsatile GH release for fat loss, muscle repair, and deep sleep without raising cortisol
